Targeting the F1Fo ATP synthase

Modulation of the body's powerhouse and its implications for human disease

John A Johnson, Mourad Ogbi

Research output: Contribution to journalReview article

25 Citations (Scopus)

Abstract

Throughout our lifetime the F1Fo ATP synthase produces the majority of our biological energy, and plays central roles in the structure and organization of mitochondria, yet our understanding of its roles in human disease remain largely enigmatic. It seems logical that even intermittent impairment of this highly important enzyme could deprive the body's tissues of energy at crucial times, which may predispose or contribute to illness. Indeed, evidence is accumulating that there are dire consequences of energy depletion in acute lifethreatening conditions, such as heart attacks, as well as chronic diseases, including aging, cancer, diabetes and heart failure. Recent advances in our understanding of the expanding roles of F1Fo ATP synthase, and how it is regulated, combined with the development of novel strategies for manipulating its function, may provide renewed hope for therapeutic improvement of energy homeostasis, and mitochondrial integrity, in a host of human diseases. In this review we will highlight what is known about the molecular regulation of this amazing enzyme complex, discuss effects of physiological agonists and therapeutic drugs on its functions, and present evidence supporting its involvement in the ills of mankind. Finally, we will outline existing challenges, and promising new avenues for targeting the enzyme therapeutically.

Original languageEnglish (US)
Pages (from-to)4684-4714
Number of pages31
JournalCurrent Medicinal Chemistry
Volume18
Issue number30
StatePublished - Oct 1 2011

Fingerprint

Adenosine Triphosphate
Modulation
Enzymes
Mitochondria
Medical problems
Heart Diseases
Homeostasis
Chronic Disease
Heart Failure
Aging of materials
Myocardial Infarction
Tissue
Therapeutics
Pharmaceutical Preparations
Neoplasms
isofenphos

Keywords

  • Disease
  • FF ATP synthase
  • Kinases
  • Mitochondria
  • Oxidative phosphorylation
  • Subunits

ASJC Scopus subject areas

  • Biochemistry
  • Molecular Medicine
  • Pharmacology
  • Drug Discovery
  • Organic Chemistry

Cite this

Targeting the F1Fo ATP synthase : Modulation of the body's powerhouse and its implications for human disease. / Johnson, John A; Ogbi, Mourad.

In: Current Medicinal Chemistry, Vol. 18, No. 30, 01.10.2011, p. 4684-4714.

Research output: Contribution to journalReview article

@article{b4932aa36526410dac4835d5bbd2f3ea,
title = "Targeting the F1Fo ATP synthase: Modulation of the body's powerhouse and its implications for human disease",
abstract = "Throughout our lifetime the F1Fo ATP synthase produces the majority of our biological energy, and plays central roles in the structure and organization of mitochondria, yet our understanding of its roles in human disease remain largely enigmatic. It seems logical that even intermittent impairment of this highly important enzyme could deprive the body's tissues of energy at crucial times, which may predispose or contribute to illness. Indeed, evidence is accumulating that there are dire consequences of energy depletion in acute lifethreatening conditions, such as heart attacks, as well as chronic diseases, including aging, cancer, diabetes and heart failure. Recent advances in our understanding of the expanding roles of F1Fo ATP synthase, and how it is regulated, combined with the development of novel strategies for manipulating its function, may provide renewed hope for therapeutic improvement of energy homeostasis, and mitochondrial integrity, in a host of human diseases. In this review we will highlight what is known about the molecular regulation of this amazing enzyme complex, discuss effects of physiological agonists and therapeutic drugs on its functions, and present evidence supporting its involvement in the ills of mankind. Finally, we will outline existing challenges, and promising new avenues for targeting the enzyme therapeutically.",
keywords = "Disease, FF ATP synthase, Kinases, Mitochondria, Oxidative phosphorylation, Subunits",
author = "Johnson, {John A} and Mourad Ogbi",
year = "2011",
month = "10",
day = "1",
language = "English (US)",
volume = "18",
pages = "4684--4714",
journal = "Current Medicinal Chemistry",
issn = "0929-8673",
publisher = "Bentham Science Publishers B.V.",
number = "30",

}

TY - JOUR

T1 - Targeting the F1Fo ATP synthase

T2 - Modulation of the body's powerhouse and its implications for human disease

AU - Johnson, John A

AU - Ogbi, Mourad

PY - 2011/10/1

Y1 - 2011/10/1

N2 - Throughout our lifetime the F1Fo ATP synthase produces the majority of our biological energy, and plays central roles in the structure and organization of mitochondria, yet our understanding of its roles in human disease remain largely enigmatic. It seems logical that even intermittent impairment of this highly important enzyme could deprive the body's tissues of energy at crucial times, which may predispose or contribute to illness. Indeed, evidence is accumulating that there are dire consequences of energy depletion in acute lifethreatening conditions, such as heart attacks, as well as chronic diseases, including aging, cancer, diabetes and heart failure. Recent advances in our understanding of the expanding roles of F1Fo ATP synthase, and how it is regulated, combined with the development of novel strategies for manipulating its function, may provide renewed hope for therapeutic improvement of energy homeostasis, and mitochondrial integrity, in a host of human diseases. In this review we will highlight what is known about the molecular regulation of this amazing enzyme complex, discuss effects of physiological agonists and therapeutic drugs on its functions, and present evidence supporting its involvement in the ills of mankind. Finally, we will outline existing challenges, and promising new avenues for targeting the enzyme therapeutically.

AB - Throughout our lifetime the F1Fo ATP synthase produces the majority of our biological energy, and plays central roles in the structure and organization of mitochondria, yet our understanding of its roles in human disease remain largely enigmatic. It seems logical that even intermittent impairment of this highly important enzyme could deprive the body's tissues of energy at crucial times, which may predispose or contribute to illness. Indeed, evidence is accumulating that there are dire consequences of energy depletion in acute lifethreatening conditions, such as heart attacks, as well as chronic diseases, including aging, cancer, diabetes and heart failure. Recent advances in our understanding of the expanding roles of F1Fo ATP synthase, and how it is regulated, combined with the development of novel strategies for manipulating its function, may provide renewed hope for therapeutic improvement of energy homeostasis, and mitochondrial integrity, in a host of human diseases. In this review we will highlight what is known about the molecular regulation of this amazing enzyme complex, discuss effects of physiological agonists and therapeutic drugs on its functions, and present evidence supporting its involvement in the ills of mankind. Finally, we will outline existing challenges, and promising new avenues for targeting the enzyme therapeutically.

KW - Disease

KW - FF ATP synthase

KW - Kinases

KW - Mitochondria

KW - Oxidative phosphorylation

KW - Subunits

UR - http://www.scopus.com/inward/record.url?scp=80053484553&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=80053484553&partnerID=8YFLogxK

M3 - Review article

VL - 18

SP - 4684

EP - 4714

JO - Current Medicinal Chemistry

JF - Current Medicinal Chemistry

SN - 0929-8673

IS - 30

ER -